Investors in Health

Vantage Value is an experienced, highly motivated team of economically thinking and acting individuals. Whether you are a start-up or an established company in the fields of innovation, precision, and medical technology, they are reliably at your side throughout various financing and development phases.

CARMA FUND I is an early-stage investment fund for advancing Life Science and Healthcare technologies. The fund started off with a First Closing in June 2022 and has €50M under management. It is based in Munich and Frankfurt am Main.

FX Ventures is a private investment company focused on venture capital and real estate related investments. FX Ventures' investment portfolio currently includes private companies in the healthcare, travel & leisure, technology and real estate industries.

Pfizer Healthcare Hub: London connects digital innovators in healthcare with industry experts. Launched in 2017, the ‘Pfizer Healthcare Hub: London’ aims to help innovative digital health companies, who have demonstrated their potential to transform the lives of patients, by connecting them to expertise within Pfizer and its networks in the UK and beyond. As part of a global network of Pfizer Healthcare Hubs, the UK Hub aims to work with some of the best and brightest health tech start-ups pursuing the vision of transforming people’s lives through innovative solutions to real-world problems.

They set themselves apart from many investors by providing management know-how in addition to the necessary financial resources. Their team consists of experts with many years of experience in company management and start-up consulting. Excellent scientists and experienced managers thus form a successful symbiosis. They see themselves as entrepreneurs within the company and help to make ideas and visions a success.

G-FUNDs focus are next-gen consumer businesses in the areas of nutrition & food, digital health & wellness, clean beauty & cosmetics, sustainable fashion & clothing, as well as digital education. They are a cross-over of generations. Combining the wisdom of investing with the stamina to accelerate models for the new consumer.

KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I) is an early-stage life sciences venture fund with €70 million under management. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. KHAN-I focuses on first-in-class therapies for attractive markets with a high unmet medical need.

Cleverage Venture Capital specializes in fostering growth for innovative startups through strategic investments and expert guidance. We support visionary entrepreneurs with the resources and connections needed to scale their businesses successfully. Partner with us to turn your cutting-edge ideas into market-leading enterprises.

Brook Fund is a dynamic venture capital firm focused on nurturing high-growth startups in the UK and beyond. We provide strategic funding, expert mentorship, and industry connections to help innovative companies scale and succeed. Partner with us to transform groundbreaking ideas into thriving businesses.

Early Game Ventures is an early-stage VC focused on identifying and investing in the best tech startups in Central and Eastern Europe, with a focus on Romania. The fund focuses on 11 themes, both B2B and B2C with special focus on Enterprise Software, Cybersecurity, Dev Tools and Ed Tech, targeting founders addressing big markets. Driven by a conviction-based approach, Early Game Ventures prefers to lead investments at Pre-Seed stage, while also investing at Seed stage and in follow-ons at Series A. Sweet spot initial ticket is €500,000 - €2 million per startup with the capacity to invest up to €6 million per company over time. The fund supports rapid globalization of its portfolio companies and provides direct in-depth advice to help founders overcome the 0 to 1 hurdles.

re.Mind Capital is a venture capital fund founded by Christian Angermayer, together with partners Jan Hardorp and Max de Vere. Venture capital fund dedicated to mental and neurological health. They focus on new pharma, new modalities, brain computer interfaces and digital health.

BVP is a venture firm celebrating 20 years in business, having evolved from a boutique corporate finance advisory into a multi-asset investment platform. Specializing in early and growth stage investments, BVP focuses on health, climate, mobility, and technology, backing ambitious entrepreneurs and tailoring solutions to the unique needs of their companies. Guided by principles of transparency, sustainability, and resilience, BVP leverages its deep market insight and two decades of experience to provide flexible investment strategies, including both debt and equity, to support the growth of impactful businesses.